Ashton Thomas Private Wealth, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2019663
SCOTTSDALE, AZ
Position in VRTX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,141,356
+$6,596 QoQ
Shares Held
2,556
+2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ashton Thomas Private Wealth, LLC holds $8,478,289 across 12 Biotechnology names. VRTX ranks #3 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
33,597 | $3,162,149 | |
| 2 | EXEL |
Exelixis, Inc.
|
26,638 | $1,142,503 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,556 | $1,141,356 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
15,234 | $984,573 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
38,292 | $948,109 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
2,194 | $438,032 | |
| 7 | ARGX |
Argenx SE
|
284 | $207,391 | |
| 8 | NAUT |
Nautilus Biotechnology, Inc.
|
45,000 | $174,600 |
All Filings in VRTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,141,356 | 2,556 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,134,760 | 2,503 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $945,418 | 2,414 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $944,714 | 2,122 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,135,448 | 2,342 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $840,434 | 2,087 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,065,498 | 2,291 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,096,336 | 2,339 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $938,850 | 2,246 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $791,807 | 1,946 | Shares | Sole | 2024-04-22 | |
| 2023-09-30 | $314,009 | 903 | Shares | Sole | 2024-04-22 | |
| 2023-06-30 | $313,903 | 892 | Shares | Sole | 2024-04-23 | |
| 2023-03-31 | $273,480 | 868 | Shares | Sole | 2024-04-23 | |
| 2022-12-31 | $268,276 | 929 | Shares | Sole | 2024-04-22 | |
| 2022-09-30 | $252,768 | 873 | Shares | Sole | 2024-04-22 | |
| 2022-06-30 | $266,009 | 944 | Shares | Sole | 2024-04-22 | |
| 2022-03-31 | $232,002 | 889 | Shares | Sole | 2024-04-22 | |
| No filing history on record for this holder in this stock. | ||||||